Picture of Kiora Pharmaceuticals logo

KPRX — Kiora Pharmaceuticals News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareAdventurousMicro CapNeutral

Kiora Pharmaceuticals Inc reports results for the quarter ended September 30 - Earnings Summary

* Kiora Pharmaceuticals Inc  KPRX.OQ  reported a quarterly
adjusted loss of 81 cents​​ per share for the quarter ended
September 30, higher than the same quarter last year, when the
company reported EPS of $-8.01.  The mean expectation of
three analysts for the quarter was for a loss of 76 cents per
share. Wall Street expected results to range from -90 cents
to -66 cents per share.
    * Reported revenue was zero​; analysts expected $7.00
thousand. 
    * Kiora Pharmaceuticals Inc's reported EPS for the quarter
was a
loss of 81 cents​.
    * The company reported a quarterly loss of $3.41 million.
    * Kiora Pharmaceuticals Inc shares had fallen by 2.5% this
quarter and lost 24.1% so far this year.

FORECAST CHANGES
    * The mean earnings estimate of analysts had fallen by
about 11.4%
in the last three months.​ 
    * In the last 30 days, there have been no earnings estimate
revisions by analysts covering the company.

RECOMMENDATIONS
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 3 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell." 
    * The average consensus recommendation for the biotechnology
&
medical research peer group is also "buy"

Wall Street's median 12-month price target for Kiora
Pharmaceuticals Inc is $27.00 
This summary was machine generated from LSEG data November 8 at
08:58 p.m. UTC. ​All figures in US dollars unless otherwise
stated. (For questions concerning the data in this report,
contact Estimates.Support@lseg.com. For any other questions or
feedback, contact RefinitivNewsSupport@thomsonreuters.com) QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Sep. 30 2024      -0.76          -0.81          Missed
 Jun. 30 2024      -0.86          -0.53          Beat
 Mar. 31 2024      -0.59          3.42           Beat
 Dec. 31 2023      -3.77          -4.23          Missed

Recent news on Kiora Pharmaceuticals

See all news